iLite RANKL*

Artikelnummer: EUD-BM4052
Artikelname: iLite RANKL*
Artikelnummer: EUD-BM4052
Hersteller Artikelnummer: BM4052
Alternativnummer: EUD-BM4052
Hersteller: Svar Life Science
Kategorie: Zellen/Zellkultur

This iLite® RANKL reporter assay enables precise quantification of RANKL activity or blockade in a cell-based system. Supports evaluation of osteoimmunology-targeting therapeutics.

  • High sensitivity and large dynamic range
  • "Assay-ready" format for rapid and convenient use
  • Reproducible and biologically relevant results
  • Reduced assay variability and higher reproducibility compared to cells in culture
  • Normalization of cell counts and serum matrix effects using a second reporter gene

 

Product Overview

The iLite® RANKL Assay Ready Cells can be used for the quantification of RANKL activity, RANKL inhibitor activity or immunogenicity studies and determination of neutralizing antibody response against RANKL inhibitors in test samples, including human serum.

iLite® RANKL Assay Ready Cells are human HEK293* cells genetically engineered and optimized to be responsive to human soluble RANK Ligand (RANKL), resulting in a proportional expression of Firefly Luciferase. Normalization of cell counts, and serum matrix effects is obtained by a second reporter gene, a Renilla Luciferase reporter gene construct, under control of a constitutive promotor.

*The HEK-293 cell line has been used under a license obtained from AdVec Inc.

 

What's in the box?

 

>250 µL of Assay Ready Cells suspended in cryoprotective medium.

 

Specifications

Product code BM4052
Assay target RANKL
Size 1 vial corresponding to one 96 well plate
Technology Cell-based reporter gene assay
Detection system Luminescence
Regulatory status Research Use Only
Formulierung: Assay Ready Cells
RANKL